{"disease":{"id":"acute-lung-injury-ali","name":"acute lung injury ali"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT04402866","title":"TD-0903 for ALI Associated With COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT07225257","title":"Recovery of Physical Function After Critical Illness In Older Adults","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Kentucky","has_results":false},{"nct_id":"NCT06853223","title":"This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06737705","title":"Baricitinib for Respiratory Injury in Patients With Intracerebral Hemorrhage","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"De-zhi Kang","has_results":false},{"nct_id":"NCT07145814","title":"Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"People's Hospital of Guangxi Zhuang Autonomous Region","has_results":false},{"nct_id":"NCT04546919","title":"Effect of R-spondin3 on Sepsis Induced Endothelial Dysfunction","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04350736","title":"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Theravance Biopharma","has_results":false},{"nct_id":"NCT05091723","title":"TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Theravance Biopharma","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}